Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
BioTech & Genomics ETFs
Aggregate data of 6 funds
Performance
Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | -1.26% | -3.70% | -0.29% | +25.80% | +9.31% | |
| Flows | -$70M | -$79M | -$11M | -$256M | -$829M | - |
Just published in BioTech & Genomics
Are Biotechnology ETFs In the Midst of a Comeback?
Biotech stocks are under pressure in 2025, but these ETFs may offer turnaround potential.
Movers in BioTech & Genomics
Data period: March 3 - 10, 2026
Performance lists exclude leveraged and inverse ETFs
Latest news about Thematic Investing: BioTech & Genomics
Are Biotechnology ETFs In the Midst of a Comeback?
Biotech stocks are under pressure in 2025, but these ETFs may offer turnaround potential.
Biotech ETFs – Investing in Health Innovation
With biotech ETFs investors may be able to diversify and gain exposure to biotech companies with less risk and smoother long-term returns.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
Asset TV
The ETF Show - US-Iran Conflict Sends Oil ETFs Soaring
Lance McGray, Managing Director and Head of ETF Product at Advisors Asset Management joins The ETF Show.
What’sTheFund
What's the Fund | Thrivent Small Cap Value ETF (Ticker: TSCV)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small Cap Value ETF (TSCV).
What’sTheFund
What's the Fund | Thrivent Small-Mid Cap Equity ETF (Ticker: TSME)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small-Mid Cap Equity ETF (TSME).
What’sTheFund
What's the Fund | Thrivent Mid Cap Value ETF (Ticker: TMVE)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Mid Cap Value ETF (TMVE).
Browse all educational columns
Have you tried our ETF Compare tool?
Compare ETFs like a pro. Analyze fees, performance, exposure & holdings side-by-side.